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Abstract: The objective of this study was to characterize
the physicochemical, dissolution, and osteogenic properties
of radio frequency magnetron sputtered dicalcium pyro-
phosphate/tricalciumphosphate (Pyro/TCP) and hydroxyl-
apatite (HA) coatings. Therefore Pyro/TCP and HA coatings
were deposited on grit-blasted titanium discs. The results
showed that the deposited coatings were amorphous and
changed into a crystalline structure after IR heat-treatment of
5508C for HA and 6508C for Pyro/TCP. Heat-treated HA
coatings appeared to be stable during immersion in simu-
lated body ﬂuid (SBF), that is no changes in the XRD pattern
were observed. Also, no dissolution of the coating was
observed by scanning electron microscopy (SEM). Energy
dispersive spectroscopy (EDS) revealed that the Ca/P ratio
of the HA coatings remained constant during SBF immer-
sion. On the other hand, the heat-treated Pyro/TCP coatings
showed a surface reaction of calcium pyrophosphate into a
b-tricalcium phosphate phase during SBF immersion. This
was conﬁrmed by EDS analysis. Rat bone marrow-derived
osteoblast-like cells cultured on the heat-treated substrates
showed that cell proliferation and differentiation occurred
on both types of bioceramic coatings. No signiﬁcant differen-
ces for proliferation and early differentiation were observed
between cells cultured on heat-treated Pyro/TCP and HA at
individual time points. However, osteocalcin expression, a
late marker for osteoblast-like cell differentiation, was signif-
icantly increased after 12 days of culture on HA-coatings.
These results were conﬁrmed by SEM observations and sug-
gest increased osteogenic properties for HA-coatings over
Pyro/TCP-coatings. Additional research is necessary to
obtain conclusive evidence on the in vivo osteogenic capacity
of Pyro/TCP coatings.  2007 Wiley Periodicals, Inc.
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INTRODUCTION
Calcium phosphate (CaP) coatings have been used
for medical and dental implants because of their supe-
rior bone biocompatibility and osteointegrative prop-
erties.1 Various coating techniques are available for
the deposition of calcium phosphate on titanium
implants, such as plasma-spray technique,2 ion plat-
ing,3 radio frequency (RF) magnetron sputtering,4 ion
beam dynamic mixing,5 and electrostatic spray deposi-
tion.6–8 RF magnetron sputtering deposition has some
clear advantages compared to other CaP deposition
techniques. These advantages include the production
of stable, dense, adherent, and homogeneous thin
Ca-P coatings on a metal substrate.9 Frequently, these
coatings have an amorphous structure directly after
deposition, which can easily be transformed into crys-
talline phases by rapid heat treatment with, for exam-
ple, infrared radiation.10 Recently, a lot of attention
has been paid to pyrophosphate (Pyro) ceramics. As
an intermediate product in the biological mineraliza-
tion process, Pyro has been demonstrated to have
great potential as an in vivo biodegradable bone substi-
tute.11 Synthetic Pyro can inhibit osteoclastic bone
resorption, and therefore is used for the treatment of
bone diseases including tumor-induced hypercalcemia
and osteoporosis.12,13 Previous studies in our labora-
tory demonstrated that Pyro can also be applied as a
coating on titanium using RF magnetron sputtering.4
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The dissolution behavior in simulated body ﬂuid of RF
magnetron sputtered Pyro coatings was similar as com-
pared to HA coatings. Further, rat bone marrow osteo-
blast-like cells proliferated only on crystalline magnetron
sputtered Pyro and HA coatings, during which crystal-
line HA coatings induced an earlier osteogenic effect
than crystalline Pyro coatings.14–17 Different approaches
are applied to improve the osteogenic capacity of bioma-
terials. Among them, the use of osteogenic cells and add-
ing growth factors are common approaches. Further,
modiﬁcation of the physicochemical properties of an
implant material, like composition, crystallinity, and
macro- and microporosity, is another potential method
to improve the osteogenic capacity.18 For example, po-
rous hydroxylapatite ceramic was shown to be less osteo-
conductive than a biphasic calcium phosphate (BCP).17
Also, other studies conﬁrmed that BCP ceramics, com-
posed of a mixture of HA and b-tricalciumphosphate (b-
TCP), induce increased bone formation when implanted
compared to pure HA ceramic.19–21
In view of the above mentioned, the objective of this
study was to characterize the physicochemical and
dissolution behavior of Pyro/b-TCP and HA coatings
obtained by RF magnetron sputtering as well as their
effect on the behavior of osteoblast-like cells.
MATERIALS ANDMETHODS
Materials
For the experiments, titanium substrates with a diameter
of 12 mm and thickness of 2 mm were used. All the discs
were Al2O3 grit-blasted at one side (Ra¼ 1.0–1.3 lm) prior to
coating deposition. RF magnetron sputter deposition was
performed using an Edwards High Vacuum ESM 100 sputter
system. The target materials used for the deposition were ei-
ther a mixture of 50% Pyro (b-Ca2P2O7)/50% b-TCP
(Ca3(PO4)2) or HA (Ca5(PO4)5OH) granulate.
RF magnetron sputtering
The substrates were mounted on a rotating and water-
cooled substrate holder. The distance between target and
substrate was 80 mm. Before sputtering the metal substrates
were cleaned by etching for 10 min with argon ions. During
deposition, argon pressure was kept at 53 103 mbar. Pyro/
TCP and HA coatings were prepared at a discharge power of
400 W with coating thickness of 2 lm. After deposition, the
as-coated specimens were subjected to an additional infrared
heat treatment for 30 s, for which the settings were based on
previous experiments4; the Pyro/TCP coatings at 6508C and
the HA coatings at 5508C (Quad Ellipse Chamber, Model E4-
10-P, Research).
Characterization of the coatings
As-deposited coatings and heat-treated coatings were
characterized using the following techniques:
X-ray diffraction
The crystallographic structure of each coating was deter-
mined by thin ﬁlm X-ray diffraction (XRD) using a Philips u-
2u diffractometer (PW 3710, 40 kV, 40 mA) using a CuKa-
radiation of 1.5418 A˚ wavelength. For these measurements,
the specimens were scanned from 20–398 (2h) at a scanning
speed of 0.0088/s and a stepsize of 0.018 (2h).
Fourier transform infrared spectroscopy
The infrared spectra of the coatings on the substrates were
obtained by reﬂection Fourier transform infrared spectroscopy
(FTIR) (Spectrum One, Perkin-Elmer), since infrared radiation
cannot pass through the titanium substrate. The coatings were
analyzed in the range of 4000–400 cm1 at 2 cm1 resolution
and 16 scans. All spectra were recorded at ambient temperature.
Scanning electron microscopy
The surface morphology of the coatings was examined
using SEM using a Jeol 6310 SEM at an accelerating voltage
of 10 kV after Au coating.
Energy dispersive spectroscopy
The above described scanning electron microscope was
equipped with an energy-dispersive X-ray microanalyzer
(Voyager). Energy dispersive spectroscopy (EDS) was car-
ried out at a magniﬁcation of 5003 at an accelerating voltage
of 10 kV to determine the elemental composition of depos-
ited coatings. Stochiometric hydroxylapatite discs of known
Ca/P ratio and of equal thickness to the coated Ti-substrates
(1.5 mm) were used as a reference for the determination of
Ca/P ratios of the deposited Ca/P coatings.
In vitro bioactivity assay
Specimens (heat-treated) were immersed in 4 mL simu-
lated body ﬂuid (SBF) with a pH of 7.2 at 378C (Table I).22 At
time points 1, 2, 3, and 4 weeks, the SBF buffer solution was
refreshed. The specimens were retrieved out of the SBF solu-
tion, thoroughly rinsed in milliQ, and dried at room temper-
ature. Subsequently, the specimens were characterized using
XRD, FTIR, SEM, and EDS, as described previously.
TABLE I
Concentrations of Ionic Species (mM) in Simulated Body
Fluid (SBF) and Human Blood Plasma (HBP)
Ions Na K Ca Mg Cl CO3 PO4 SO4
SBF 142 5 2.5 1.5 148 4.2 1 0.5
HBF 142 5 2.5 1.5 103 27 1 0.5
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Cell culture experiment
Isolation of rat bone marrow cells
Cells were isolated and cultured using the method
described by Maniatopoulos et al.23 Brieﬂy, bone marrow
cells were obtained from femora of male Wistar rats. Femora
were washed four times in a-MEM (Gibco) with 0.5 mg/mL
gentamycin and 3 lg/mL fungizone. Epiphyses were cut off
and diaphyses ﬂushed out with 15 mL a-MEM, supple-
mented with 10% fetal calf serum (FCS), 50 lg/mL ascorbic
acid, 50 lg/mL gentamycin, 10 mM Na b-glycerophosphate,
and 108M dexamethasone. Cells were incubated in a
humidiﬁed atmosphere (95% air; 5% CO2; 378C). The me-
dium was changed three times a week. After 7 days of pri-
mary culture, cells were detached using 0.25% w/v trypsin
and counted using a Coulter1 counter. Experimental sub-
strates were placed at the bottom of 24-well plates, and 1 mL
cell suspension (4.0 3 104 cells/mL) was added to the sub-
strates. Medium was refreshed three times a week.
Proliferation assay
To determine cellular proliferation, cellular protein con-
centrations were measured with a micro BCA (bicinchoninic
acid) protein assay (Pierce). After 4, 8, 12, and 16 days, exper-
imental substrates were washed twice with PBS and
immersed in milliQ. Subsequently, three repetitive freeze/
thaw cycles were carried out prior to the assay. For the assay,
100 lL of sample was incubated with 100 lL working solu-
tion for 2 h at 378C. Serial dilutions of BSA (2–200 lg/mL)
were used for standard curve. The plate was read at 570 nm
in an ELISA plate reader (Bio-Tek). A total of three inde-
pendent runs were performed, in which at each time point,
four substrates per condition were used (n ¼ 4).
Differentiation assay
To determine cell differentiation, alkaline phosphatase
(ALP) activity was measured at 4, 8, 12, and 16 days using
the same samples as those from the proliferation assay.
Eighty microliters of sample and 20 lL of alkaline buffer
(Sigma, Zwijndrecht, The Netherlands) were added to
100 lL of substrate solution (5 mM paranitrophenylphos-
phate: Sigma). For the standard curve, serial dilutions of 4-
nitrophenol (0–25 nmol/mL) were made. The plate was
incubated at 378C for 60 min. The reaction was stopped by
the addition of 100 lL of 0.3M NaOH, after which the plate
was read in an ELISA reader (Bio-Tek, USA). A total of three
independent runs were performed, in which at each time
point, four substrates per condition were used (n ¼ 4). Mea-
surements were then normalized for protein assay.
Osteocalcin assay
Osteocalcin (OC) was measured in the cell cultures by
enzyme immunoassay (EIA; Biomedical Technologies). After 8,
12, 16, and 24 days of culture, samples were collected by scrap-
ing in EIA sample buffer and sonicated for 10 min. About
100 lL of sample was added to the wells and the plate was
incubated at 48C for 18 h. The plate was washed three times,
100 lL of antiserum was added, and the plate was incubated
for 1 h at 378C. After washing three times, 100 lL of donkey
anti-goat IgG peroxidase was added and incubated for 1 h at
room temperature. The plate was washed, 100 lL of substrate
solution (1 volume TMB (3,31,5,51)-tetramethylbenzidine)/1
volume H2O2) was added, and the plate was incubated for 30
min. Then 100 lL stop solution was added and the plate was
read at 450 nm in an ELISA plate reader. A total of three inde-
pendent runs were performed, in which at each time point,
four substrates per condition were used (n¼ 4).
Cell morphology
Samples with cells for SEM were ﬁxed in 2% glutaralde-
hyde, washed twice in 0.1M sodium-cacodylate buffer (pH
7.4), and dehydrated using a graded series of ethanol. After
drying with tetramethylsilane, samples were sputter-coated
with gold and examined using a Jeol 6310 SEMwith an accel-
eration voltage of 15 kV.
Statistical analysis
The entire cell culture experiment was preformed three
times, and for each cell culture run cells were isolated from one
individual rat. Differences between experimental groups were
calculated using an ANOVA followed by a Student-Newman-
Keuls test. Calculations were performed in GraphPad Instat,
Version 3.05 (GraphPad Software, San Diego, CA).
RESULTS
Coating characterization before and
after heat treatment
X-ray diffraction
The XRD patterns of the as-deposited coatings showed
an amorphous structure with no clear reﬂection, only the
underlying substrate peaks were visible (Fig. 1). Infrared
heat-treatment at 5508C changed the amorphous sput-
Figure 1. XRD patterns of sputtered Ca-P coatings. The
major peaks have been marked: A, apatite; P, pyrophos-
phate; T, tri-calciumphosphate; S, substrate (titanium).
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tered HA coating into a crystalline apatite structure with
reﬂections 002, 211, 112, 202 at respectively 25.98, 31.98,
32.48 and 34.08 (2h), comparative with the XRD pattern of
HA powder (JCPDS No. 09-0432). The sputtered amor-
phous pyrophosphate/tricalciumphosphate coating re-
quired an annealing temperature of 6508C. The amor-
phous phase changed into two crystalline phases, a beta
calcium pyrophosphate structure with peaks at 26.68,
27.78, 28.58 and 29.58 (2h) and a b-tricalciumphosphate
structure with peaks at 25.78, 31.08 and 34.48 (2h).
Fourier transform infrared spectroscopy
Figure 2 shows the FTIR spectra of the as-deposited
and heat-treated Pyro/TCP and HA coatings. All as-de-
posited Pyro/TCP and HA coatings show two clusters
of peaks from 900–1150 and from 550–600 cm1, which
can be attributed to the major absorption modes of phos-
phate bonds (Fig. 2). Infrared heat treatment of the HA
coatings resulted in the appearance of various PO
bonds at a wavelength around 567, 587, 1009, and 1083
cm1, characteristic for apatite. The spectrum of the heat-
treated Pyro/TCP coating revealed characteristics of a
mixture of b-calcium pyrophosphate and b-tricalcium
phosphate phases with various PO bands at wave-
lengths of 523, 587, 612, 648, 970, 998, 1081, 1102, 1124,
1152, and 1203 cm1.
Scanning electron microscopy
SEM examination of the sputtered coatings showed
an excellent coverage of the substrate surface. Infrared
heat treatment had no effect on the coating morphol-
ogy [Fig. 3(a-d)].
Energy dispersive spectroscopy
EDS analysis revealed that Ca/P ratios of amor-
phous as well as crystalline coatings was*1.436 0.03
for Pyro/TCP, 1.976 0.05 for HA (Table II).
In vitro bioactivity
X-ray diffraction
The XRD evaluation conﬁrmed that the heat-treated
Pyro/TCP and HA coatings were still present after 4
weeks of immersion in SBF [Fig. 4(a,b)]. The XRD pat-
terns of the heat-treated Pyro/TCP and HA coatings
did not change during incubation.
Fourier transform infrared spectroscopy
Figure 5(a,b) depicts the FTIR spectra of the SBF
immersed coatings. Heat-treated Pyro/TCP and HA
coatings showed stable FTIR spectra, almost no
changes could be observed during 4 weeks of immer-
sion in SBF.
Scanning electron microscopy
After immersion in SBF, SEM examination of the
heat treated Pyro/TCP and HA coatings showed no
change in morphology [Fig. 3(b-d)].
Energy dispersive spectroscopy
EDS examination showed that the Ca/P ratio of the
HA coatings remained constant during SBF immer-
sion, while the Pyro/TCP coatings changed from 1.43
to 1.70 after incubation in SBF (Table II).
Cell culture experiment
A total of three experimental runs were carried out,
which showed similar results for proliferation, differ-
entiation, and morphology. Below, results of one rep-
resentative experimental run are presented.
Proliferation assay
The data are shown in Figure 6. For heat-treated
coatings, protein content increased from day 4 to day
16 of culture at individual time points. No signiﬁcant
difference in protein content was observed between
heat-treated Pyro/TCP and HA coatings (p > 0.05).
Figure 2. FTIR spectra of sputtered Ca-P coatings.
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Alkaline phosphatase activity assay
The data are shown in Figure 7. ALP activity
increased to a maximum on day 16 on Pyro/TCP coat-
ings. For heat-treated HA coatings, ALP activity
increased from day 4 and reached a maximum at day
8–12. No signiﬁcant difference in ALP expression was
observed between heat-treated Pyro/TCP and HA at
individual time points (p > 0.05).
Osteocalcin assay
The data are shown in Figure 8. For both heat-
treated coatings, OC expression increased from day 8
Figure 3. SEM pictures of coatings as-sputtered, heat-treated, and after incubation in SBF. (a–c) Pyro/TCP as-sputtered, and
after 2 and 4 weeks SBF immersion; (d–f) HA as-sputtered, and after 2 and 4 weeks SBF immersion (Original magniﬁcation
31000).
TABLE II
EDSMeasurement of the Ca/P Ratio of the Heated Coatings Before and After Incubation in SBF
Week Initial 1 2 3 4
Pyro/TCP 1.436 0.03 1.566 0.05 1.456 0.10 1.706 0.06 1.656 0.03
HA 1.976 0.05 1.986 0.07 1.936 0.09 2.016 0.03 1.926 0.03
Values are mean6 SD.
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to a maximum at day 16. After 12 days of culture, the
OC expression on the heat treated HA coatings was
signiﬁcantly higher (p < 0.01) compared to the heat-
treated Pyro/TCP coatings.
Cell morphology
After 8 days, cells started to form a multilayer on
both Pyro/TCP and HA coatings. No apparent differ-
ence in cell morphology could be discerned between
the two types of ceramic coating. After 24 days of cul-
ture, the cells had formed a layer of calciﬁed globular
accretions associated with collagen bundles. On the
Pyro/TCP coatings, the cells had proliferated well and
showed massive collagen ﬁber formation and surface
mineralization in the form of globular accretions. On
HA coatings, this process was observed to occur some-
what earlier (Fig. 9).
DISCUSSION
The purpose of this study was to characterize the
physicochemical and dissolution behavior of Pyro/
TCP and HA coatings obtained by RF magnetron sput-
tering. In addition, the in vitro cell behavior of RBM-
osteoblast-like cells on RF magnetron Pyro/TCP and
HA coatings was evaluated.
Physicochemical analysis demonstrated that as-de-
posited CaP coatings had an amorphous structure.
The additional IR heat treatment induced crystal
growth within the coatings, resulting in a crystalline
structure. Heat treatment below 6508C did not crystal-
lize the amorphous Pyro/TCP, while amorphous HA
coatings transformed into a crystalline apatite struc-
ture at 5508C. However, after a heat-treatment at
6508C, the amorphous Pyro/TCP coatings changed
into a crystalline b-Pyro/b-TCP structure. The main
reason for the difference in crystallization can be
Figure 4. XRD patterns of sputtered Ca-P coatings after
incubation in SBF; (a) pyro/TCP coatings (b) HA coatings.
Figure 5. FTIR spectra of sputtered Ca-P coatings after
incubation in SBF; (a) pyro/TCP coatings (b) HA coatings.
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explained by the difference in activation energy for the
crystallization of apatite compared to Pyro/TCP.4 Fur-
ther, this study demonstrated that IR-radiation is an
excellent method to crystallize thin RF magnetron-
sputtered Ca-P coatings.
The EDS measurements proved that the Ca/P ratio
of the magnetron sputtered Pyro/TCP and HA coat-
ings as used in this study were higher than the theoret-
ical values, that is for Pyro/TCP 1.43 instead of 1.25
and for HA 1.97 instead of 1.67. It has been shown pre-
viously that the increase in Ca/P ratio of the Pyro/
TCP and HA is mainly caused by the effect of prefer-
ential sputtering of calcium because of the possibility
of the phosphorus ions being pumped away before
reaching the substrate.24 Further, sputtering deposi-
tion parameters, like power and Argon pressure, can
affect the ﬁnal Ca/P ratio of the sputtered coatings.25
Also the changes in Ca/P ratio of heat-treated Pyro/
TCP coating after immersion in SBF indicated that the
CaP phases are chemically instable, resulting in an
increase of Ca/P ratio. On the other hand the Ca/P ra-
tio of crystalline HA coating remained constant indi-
cating stability of this CaP phase. The increase in Ca/P
ratio of heat-treated Pyro/TCP is the result of a surface
reaction of calcium pyrophosphate into a b-TCP
phase.26 It is claimed, that this kind of surface reac-
tions beneﬁts the osteogenic properties of the CaP
coating.
A number of studies have addressed that the forma-
tion of directly bonded apatite is indicative for poten-
tial in vivo bioactivity.27 In this study, no precipitation
was observed on HA and Pyro/TCP coatings even af-
ter an incubation period of 4 weeks. This is likely
because of the Ca and PO4 concentrations of SBF solu-
tion used in the immersion experiment. Van der Wal
et al.28 indicated that the formation of a Ca-P precipi-
tate on ceramic coatings only occurs in SBFx, which is
SBF with x times the human blood plasma Ca and PO4
concentrations, with x > 1.4. Furthermore, Ca/P ratio,
crystallinity, grain size of CaP coatings, and the pres-
ence of impurities in the coatings are important factors
in the formation of CaP precipitation.
In the cell culture experiments, the proliferation of
osteoblast-like cells was measured using protein anal-
yses. Although this analysis does not measure intracel-
lular protein exclusively, the amount of protein from
other sources (e.g. extracellular matrix) will be limited
because of the use of procedures (e.g. freeze and thaw
cycles in water) with limited destructive effects on
other protein sources than cells. The current study
indicated an improved osteogenic effect of magnetron
sputtered crystalline HA coatings compared to crystal-
Figure 6. Protein content of the osteoblast-like cells on
Pyro/TCP and HA coatings at the end of the various incuba-
tion times. Values represent mean6 SD.
Figure 7. Alkaline phosphatase activity of the osteoblast-
like cells on Pyro/TCP and HA coatings at the end of the
various incubation times. Values represent mean6 SD.
Figure 8. Osteocalcin expression of the osteoblast-like cells
on Pyro/TCP and HA coatings at the end of the various
incubation times. Values represent mean6 SD. ** indicates a
signiﬁcant difference (p < 0.01).
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line Pyro/TCP coatings because the level of ALP and
OC expression, which is supposed to reﬂect differen-
ces in the degree of differentiation of osteoblastic cells,
started to increase earlier on the crystalline HA coat-
ings. This observation most likely is related to the pri-
mary instability of Pyro/TCP coatings, as Pioletti et al.
showed that dissolution of Ca-P coatings results in an
increase of interfacial ions, which may cause apoptosis
of osteogenic cells and cause damage to already
formed bone.29 Besides ions, also Ca-P particles can be
released from the materials, which again have been
shown to inhibit osteoblast function.30 In this study,
the Pyro/TCP coated ﬁlm showed no dissolution in
SBF by SEM observation. Consequently, the Pyro/TCP
coatings were not enhancing cell differentiation and
mineralization.
CONCLUSION
It can be concluded that RF magnetron sputtering
can be successfully used to deposit Pyro/TCP and HA
coatings on metal substrates, which can be trans-
formed into crystalline phases using infrared heat-
treatment. After immersion in SBF, heat-treated HA
coatings were stable and showed no change in Ca/P
ratio, whereas for Pyro/TCP coatings an increase in
Ca/P ratio was observed. No CaP precipitation was
observed on both Pyro/TCP and HA coatings
after SBF immersion up to 4 weeks. The rat bone mar-
row derived osteoblast-like cells showed improved
osteogenic response on HA coatings compared to
Pyro/TCP coatings. As it is known that in vitro data
cannot be directly extrapolated to the in vivo situation,
further investigations are necessary to obtain conclu-
sive evidence on the in vivo osteogenic capacity of
Pyro/TCP coatings.
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